Singapore markets close in 7 hours 48 minutes

Cidara Therapeutics Inc (20D.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
11.19+10.63 (+1,900.00%)
At close: 08:04AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
46,261
63,905
64,448
49,572
12,067
-
Cost of revenue
3,086
1,523
0
-
-
-
Gross profit
43,175
62,382
64,448
-
-
-
Operating expenses
Research development
61,256
68,532
77,405
73,087
68,017
-
Selling general and administrative
19,874
18,333
20,546
18,740
15,899
-
Total operating expenses
81,130
86,865
97,951
91,827
83,916
-
Operating income or loss
-37,955
-24,483
-33,503
-42,255
-71,849
-
Total other income/expenses net
-
-
-
-
-
411
Income before tax
-35,827
-22,488
-33,312
-42,467
-72,111
-
Income tax expense
-
443
272
0
0
-
Income from continuing operations
-36,270
-22,931
-33,584
-42,467
-72,111
-
Net income
-36,270
-22,931
-33,584
-42,467
-72,111
-
Net income available to common shareholders
-35,634
-22,931
-33,584
-42,467
-74,873
-
Basic EPS
-0.39
-5.20
-8.60
-16.20
-36.00
-
Diluted EPS
-0.39
-5.20
-8.60
-16.20
-36.00
-
Basic average shares
82,772
4,371
3,493
2,623
2,078
-
Diluted average shares
82,772
4,371
3,493
2,623
2,078
-